![]() |
![]() |
Legal status
Patent revoked (after opposition at EPO)
(51) | INT.CL. | C07K 16/24 | (2006.01) |
A61K 39/395 | (2006.01) | ||
A61P 37/06 | (2006.01) | ||
A61P 19/02 | (2006.01) | ||
A61K 31/519 | (2006.01) |
(11) | Number of the document | 1406656 |
(13) | Kind of document | T |
(96) | European patent application number | 02741849.0 |
Date of filing the European patent application | 2002-06-05 | |
(97) | Date of publication of the European application | 2004-04-14 |
(45) | Date of publication and mention of the grant of the patent | 2013-01-09 |
(46) | Date of publication of the claims translation | 2013-04-25 |
(86) | Number | PCT/US2002/017790 |
Date | 2002-06-05 |
(87) | Number | WO 2002/100330 |
Date | 2002-12-19 |
(30) | Number | Date | Country code |
296961 P | 2001-06-08 | US |
(72) |
KEMPENI, Joachim, DE
WEISS, Roberta, US
FISCHKOFF, Steven, A., US
|
(73) |
AbbVie Biotechnology Ltd,
Clarendon House 2, Church Street, HM 11 Hamilton,
BM
|
(74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
(54) | Anti-TNF-alfa antikūnų skyrimo būdai |
METHODS OF ADMINISTERING ANTI-TNF-ALPHA ANTIBODIES |
Payment date | Validity (years) | Amount | |
2015-05-21 | 14 | 289.00 EUR |
Patent revoked (after opposition at EPO) | ||
Invalidation date | 2015-11-26 |